-
Aseptic Processing of Biological Products: Current Regulatory Issues – FDA Presentation
The FDA’s presentation delves into regulatory standards concerning microbiology and process validation within aseptic biologics manufacturing. It highlights prevalent deficiencies uncovered during recent FDA inspections.
-
FDA Takes Action: Warning Letters Sent to Companies Selling Unapproved Eye Products
In a significant development, the U.S. Food and Drug Administration (FDA) has recently issued warning letters to eight companies found in violation of federal law due to the manufacturing or marketing of unapproved ophthalmic drug products. This move is part of the FDA’s ongoing efforts to safeguard Americans from potentially hazardous eye products. These warning…
-
Medical Cultivation of Cannabis Bill Passed by Brazil’s Chamber of Deputies
RIO DE JANEIRO, BRAZIL – The bill authorizing the legalization of controlled cultivation of cannabis sativa in Brazil for medicinal and scientific purposes was passed on Tuesday, June 8, by the Chamber of Deputies. The text was being processed by a special committee established to analyze Bill 399/15, in conclusive terms. The text was then dispensed from…
-
Medicinal Cannabis Scheme consultation
Click this link
-
Health Canada Final Regulations for New Cannabis Products.
Final Regulations for New Cannabis Products – Règlements finaux sur les nouveaux produits du cannabisHealth Canada-Final Regulations for New Cannabis Products, Effective Oct. 19, 2019
-
WHO guidelines for sampling of pharmaceutical products and related materials
Clink the link below.
-
Ascent Industries| Press Release |18 October 2018
Ascent Industries Corp. Provides Health Canada Licenses Update Click here to read this press release.
Contact us at gxpconsultingcorp@gmail.com 